Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.03
0% from low
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $30.0K | $195.6K | $284.4K |
| Cost of revenue | $0 | $0 | $0 | $0 | $50.0K | $326.0K | $246.8K | $293.3K |
| Gross profit | $0 | $0 | $0 | $0 | −$50.0K | −$296.0K | −$51.2K | −$9.0K |
| Gross margin | — | — | — | — | — | -986.7% | -26.2% | -3.2% |
| R&D | $598.0K | $1.3M | $3.1M | $3.2M | $3.5M | $1.9M | $1.1M | $125.4K |
| Operating income | −$952.1K | −$6.3M | −$12.4M | −$9.0M | −$8.0M | −$13.1M | −$7.4M | −$3.4M |
| EBITDA | −$120.0K | −$344.7K | −$1.4M | −$89.0K | −$8.0M | −$13.1M | −$7.7M | −$617.6K |
| Net income | −$1.1M | −$7.2M | −$14.5M | −$9.3M | −$10.3M | −$13.5M | −$8.2M | −$2.1M |
| Net margin | — | — | — | — | — | -44974.0% | -4213.0% | -721.7% |
| EPS (diluted) | -0.12 | -0.81 | -1.39 | -0.67 | -0.78 | -0.65 | -0.33 | -0.08 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds QBIO.
No tracked institution reports a position in QBIO as of their last filing.
| Execution date | Ratio |
|---|---|
| 2015-08-07 | 2.5-for-1 |
No one on the platform has traded QBIO yet.
| $63132 |
| — |
| RCARRenovaCare, Inc. | $0.00 | +0.00% | $8735 | — |
| RGINRegenicin, Inc. | $0.00 | +0.00% | $15348 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Fundamental analysis of $QBIO (Q BioMed Inc.) based on financial data and reported results. #QBIO
View on StockTwits ↗$QBIO 1) Too bad that their eye drop ? idea did not pan out. All these elderly people are on eye drops.. 2) There is not a good treatment for liver cancer, yet. I saw some potential in their liver cancer candidate. It's even oral pill. duh. 3) Their candidate drug for non-verbal autism could have been a game changer. Obviously, all these pipe dreams are based on assumption that they're truthful about their patents, etc.
View on StockTwits ↗$QBIO Quantum BioPharma is rapidly gaining investor attention for its next-gen therapeutic platform targeting oncology, immunology, and inflammation. Discover why analysts see QBIO as a future standout in precision-based biotech innovation. https://biotechhealthx.com/biotech-news/quantum-biopharma-qbio-emerges-as-precision-medicine-breakthrough-leader/
View on StockTwits ↗@Taketheoffer This is actually a different company. $QBIO QBIoMed is a cancer drug manufacturer, here is their website: https://www.qbiomed.com
View on StockTwits ↗$pltr $bbai sleeper $qbio https://stocktwits.com/thebagholder80/message/603420350
View on StockTwits ↗$QBIO https://www.statnews.com/2024/07/18/q-bio-preventative-scan-startup-new-mri-machine/
View on StockTwits ↗$QBIO https://www.statnews.com/2024/07/18/q-bio-preventative-scan-startup-new-mri-machine/
View on StockTwits ↗$QBIO I own 12500 shares from .55 something is up looks like they put a new site up something can be brewing https://www.q.bio
View on StockTwits ↗$QBIO [15s. delayed]: Issued Press Release on June 23, 08:00:00: Q BioMed Inc. Provides Update to Shareholders https://s.flashalert.me/2MZoga
View on StockTwits ↗$QBIO Q BioMed Inc. Provides Update to Shareholders https://www.stocktitan.net/news/QBIO/q-bio-med-inc-provides-update-to-b2ow1rtq8l6s.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.